Vision and retina check-up for children with ROP
Part of Brain & nervous system, Eyes & vision, Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at children who had ROP (an eye problem in premature babies) to see how their vision and the back of the eye (retina) develop over time. It compares children who received treatment with those who did not, to learn more about long-term effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was diagnosed with retinopathy of prematurity (ROP) at some point
- The ROP was either treated (with laser or injections) or was not treated
- Your child is at least six years old at the time of the check-up
- Your child was born in Norway or received treatment in Norway
- Your child can participate in the study's vision and eye exams
- Your child does not have another eye condition or a general disease that could affect the retina or vision
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the tiny blood vessels in the back of the eye (retina) of premature infants who are at risk for retinopathy of prematurity, a condition that can harm vision. It aims to improve care and monitoring by using advanced eye imaging to see more detail than current methods.
This study looks at the long-term eye health of people who were born prematurely and screened for a condition called retinopathy of prematurity (ROP), which affects the blood vessels in the eye. It aims to understand how their vision has developed over time.
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
This study tests a new educational program to help parents of premature babies understand the eye condition ROP (retinopathy of prematurity) and why screening is important. By taking part, you'll learn how to care for your baby's eye health and potentially prevent vision problems.
This trial tests whether a low dose of conbercept, given as an eye injection, can safely treat type 1 ROP (an eye disease in premature babies). The goal is to stop abnormal blood vessel growth and prevent vision loss.
This study tests a digital tool to help find and treat vision problems early in babies and young children who are at risk due to premature birth or brain issues. It may help improve their visual development.
Hear when a new Retinopathy of Prematurity (ROP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.